We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
-4.52%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$99.7M
AUM Growth
-$7.72M
Cap. Flow
-$1.97M
Cap. Flow %
-1.98%
Top 10 Hldgs %
20.61%
Holding
65
New
2
Increased
1
Reduced
60
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.85M
2
KR icon
Kroger
KR
+$1.74M
3
MDT icon
Medtronic
MDT
+$31.9K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$1.33M
2
GPC icon
Genuine Parts
GPC
+$288K
3
WBD icon
Warner Bros
WBD
+$149K
4
AMGN icon
Amgen
AMGN
+$149K
5
NXST icon
Nexstar Media Group
NXST
+$86.9K

Sector Composition

Rank Sector Weight
1 Financials 20.76%
2 Healthcare 18.69%
3 Industrials 10.11%
4 Technology 10.09%
5 Energy 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXST icon
1
Nexstar Media Group
NXST
$6.01B
$2.2M 2.2%
13,169
-469
-3% -$86.9K
AMGN icon
2
Amgen
AMGN
$209B
$2.19M 2.19%
9,697
-613
-6% -$149K
GPC icon
3
Genuine Parts
GPC
$17.9B
$2.16M 2.17%
14,475
-1,906
-12% -$288K
AFL icon
4
Aflac
AFL
$65.5B
$2.13M 2.14%
37,994
-1,365
-3% -$80.3K
OGE icon
5
OGE Energy
OGE
$9.87B
$2.11M 2.12%
57,870
-2,071
-3% -$83.6K
CVX icon
6
Chevron
CVX
$382B
$1.99M 2%
13,870
-483
-3% -$73.7K
MET icon
7
MetLife
MET
$62.4B
$1.96M 1.97%
32,262
-1,152
-3% -$73.6K
UL icon
8
Unilever
UL
$142B
$1.95M 1.95%
39,482
-1,414
-3% -$73.9K
CVS icon
9
CVS Health
CVS
$135B
$1.94M 1.94%
20,310
-702
-3% -$69.5K
AAPL icon
10
Apple
AAPL
$4.97T
$1.93M 1.93%
13,937
-501
-3% -$78.6K
SCHW
11
Charles Schwab
SCHW
$182B
$1.91M 1.92%
26,601
-955
-3% -$66.3K
ABBV icon
12
AbbVie
ABBV
$465B
$1.89M 1.89%
14,054
-498
-3% -$71.5K
EOG icon
13
EOG Resources
EOG
$77.7B
$1.88M 1.89%
16,847
-604
-3% -$67.8K
AMP icon
14
Ameriprise Financial
AMP
$47.8B
$1.87M 1.88%
7,425
-266
-3% -$70K
SNA icon
15
Snap-on
SNA
$21.5B
$1.82M 1.82%
9,020
-323
-3% -$69.6K
GILD icon
16
Gilead Sciences
GILD
$165B
$1.81M 1.81%
+29,289
New +$1.85M
TD icon
17
Toronto Dominion Bank
TD
$193B
$1.78M 1.79%
29,016
-1,038
-3% -$67.2K
PFG icon
18
Principal Financial Group
PFG
$24.3B
$1.78M 1.78%
24,633
-890
-3% -$63.9K
GD icon
19
General Dynamics
GD
$103B
$1.76M 1.77%
8,297
-300
-3% -$67.8K
PSX icon
20
Phillips 66
PSX
$82.9B
$1.76M 1.76%
21,764
-777
-3% -$66.2K
MRK icon
21
Merck
MRK
$322B
$1.74M 1.75%
20,210
-811
-4% -$72.4K
DGX icon
22
Quest Diagnostics
DGX
$26B
$1.74M 1.74%
14,140
-512
-3% -$67.4K
TXN icon
23
Texas Instruments
TXN
$248B
$1.73M 1.74%
11,191
-397
-3% -$66.6K
SJM icon
24
J.M. Smucker
SJM
$13.5B
$1.73M 1.73%
12,569
-440
-3% -$60K
ITW icon
25
Illinois Tool Works
ITW
$84.1B
$1.72M 1.73%
9,538
-344
-3% -$67.9K
1
2 3

Similar funds

EW
Expressive Wealth Chicago, Illinois $105M AUM
ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SPW
Signet Private Wealth Chicago, Illinois $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
NS
Northland Securities Minneapolis, Minnesota $105M AUM
ACA
Alpha Capital Advisors Bangor, Maine $105M AUM
HA
Helium Advisors Everett, Washington $105M AUM 15.41% 1-Year Est. Return

Weaver C. Barksdale & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Weaver C. Barksdale & Associates held 65 positions worth $99.7M, down 7.2% from $107M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Weaver C. Barksdale & Associates's Q3 2022 filing shows 2 new, 1 increased, 60 reduced and 2 closed positions. Its largest new stake was Gilead Sciences: 29,289 shares worth $1.81M. The largest sale was 3M, an estimated $1.33M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q3 2022 buy was Gilead Sciences: 29,289 shares worth $1.81M.
  • Weaver C. Barksdale & Associates added most to Medtronic in Q3 2022, an estimated $31.9K increase.
  • Weaver C. Barksdale & Associates's biggest Q3 2022 reduction was Genuine Parts, cutting an estimated $288K.
  • Weaver C. Barksdale & Associates fully exited 3M in Q3 2022, selling an estimated $1.33M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 21% of its $99.7M portfolio in Q3 2022.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 2 in Q3 2022.
  • Weaver C. Barksdale & Associates's portfolio value fell 7.2% quarter-over-quarter to $99.7M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q3 2022, filed 14 Nov 2022.